Mayo Clinic researchers are utilizing advanced technology to create tissue models of various body parts for the purpose of studying damaged or diseased tissues and organs. They have a vision of a future where advanced bioprinting technology can create customized treatments for intricate medical conditions.
3D bioprinters function similarly to traditional 3D printers, which are commonly used to create small plastic toys or parts. According to Kevin Dicker, Ph.D., a bioprinting expert and process development staff scientist for the Center for Regenerative Biotherapeutics in Arizona, 3D bioprinters utilize biocompatible materials with living cells to create three-dimensional tissue structures. This innovative approach has the potential to greatly enhance human health by offering an alternative to traditional materials like hard plastics or metals for constructing parts or prototypes. “Bioprinters are invaluable tools that greatly enhance research in the exciting field of tissue engineering.”
Researchers are highly interested in the possibilities of 3D bioprinting, as it offers a unique opportunity to study the development of diseases and test out innovative treatments for various conditions, including end-stage organ failure, cartilage defects, and atopic dermatitis, commonly known as eczema. Dr. Dicker and the process development team are diligently working to establish the necessary protocols for manufacturing tissue for testing in early-stage clinical trials. This groundbreaking research at the Mayo Clinic focuses on incorporating tissue engineering into practical treatments that can be examined in clinical trials.
The Mayo Clinic’s Center for Regenerative Biotherapeutics is dedicated to conducting research that pushes the boundaries of tissue engineering and cell and gene therapies. Their ultimate goal is to provide cutting-edge clinical care to patients suffering from rare and complex diseases.
Exploring the fascinating world of bioprinting using living cells
The 3D bioprinter uses a digital blueprint of a design derived from medical imaging, like MRI or CT scans, and begins the printing process. This advanced tool utilizes cutting-edge technology to accurately deposit bioinks containing living cells, hydrogels, biomaterials, and growth factors in a precise layer-by-layer manner. The final 3D tissue model it creates is capable of replicating the structure, mechanics, and physiology of human organs, muscles, or cartilage.
“It is possible to create a bioink made of gelatin-like substances that can be printed into any desired shape.” Furthermore, Dr. Dicker mentions the possibility of encapsulating living cells into a gelatin-like bioink. “This cutting-edge tissue engineering technique is a rapidly advancing field in regenerative medicine, poised to revolutionize both laboratory research and clinical practice by creating bioengineered substitutes for impaired or unhealthy tissue.”
Advancements in bioprinting have revolutionized the field of organ transplantation.
The intricate tissue structures produced by the 3D bioprinter have enabled researchers to explore methods for printing human organs. Mayo Clinic has made significant advancements in bioprinting technology to replicate the appearance and characteristics of inflammatory skin disease. The lab of Saranya Wyles, M.D., Ph.D., is currently studying a bioprinted skin model to gain insights into disease progression and test potential treatments for conditions like atopic dermatitis (eczema).
“We are proud to announce the development of a groundbreaking human skin model that accurately replicates the structure and function of real human skin.” This 3D model provides a realistic representation for studying inflammatory skin conditions. “It accurately recreates patient-specific disease and provides the ability to test new therapies,” states Dr. Wyles.
In addition to its application in disease models, this cutting-edge technology is being investigated for the production of human tissue and organs.
“The ultimate aspiration is to eventually have the capability to produce organs and tissue as needed.” However, we still have some work to do,” says Dr. Dicker. “Our goal is to further develop this technology as a potential solution to the worldwide scarcity of donor organs. If we can successfully bioprint functional kidneys, it would greatly alleviate the burden on the healthcare system.
Creating implants using bioprinting technology
David Lott, M.D., and his research team in Arizona are currently working on the development of 3D bioprinted implants specifically designed for the larynx or trachea. The implants have the potential to replace damaged or diseased portions of the organ while preserving the surrounding healthy tissue.
“The 3D bioprinter is capable of creating intricate tissue structures that include both rigid cartilage and delicate soft tissue areas. According to Dr. Dicker, we are able to create 3D-printed replicas of vocal folds, the delicate tissues involved in producing sound, as well as the cartilage that surrounds the larynx. ” Our goal is to create a cutting-edge 3D bioprinted implant that can be used to help patients who have undergone larynx removal due to disease or trauma.”
Obstacles in the field of bioprinting
Although 3D bioprinting shows promise, the Mayo Clinic and other research institutions are still facing obstacles that need to be addressed. For a bioprinted organ to effectively operate, it is crucial for it to be able to access blood, oxygen, and nutrients. Researchers have faced challenges in developing a network of capillaries and blood vessels in the bioprinted structures on a large scale to ensure the delivery of essential elements. Another obstacle is the seamless integration of bioprinted tissues with the human body, ensuring that the implant is not rejected.
3D bioprinting has the potential to revolutionize healthcare, but further research is required to gain a comprehensive understanding and practical application of this technology.
by Susan Buckles
